Skip Navigation


Carcinogenesis Advance Access originally published online on June 12, 2007
Carcinogenesis 2007 28(11):2382-2390; doi:10.1093/carcin/bgm128
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
28/11/2382    most recent
bgm128v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Yang, S.
Right arrow Articles by Meyskens, F. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yang, S.
Right arrow Articles by Meyskens, F. L., Jr
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Redox effector factor-1, combined with reactive oxygen species, plays an important role in the transformation of JB6 cells

Sun Yang1, Bobbye J. Misner1, Rita J. Chiu1 and Frank L. Meyskens, Jr*,1,2

1 Chao Family Comprehensive Cancer Center
2 Departments of Biological Chemistry and Medicine, University of California Irvine, Orange, California 92868

* To whom correspondence should be addressed. Tel: +714 456 6310; Fax: +714 456 2240; Email: flmeyske{at}uci.edu

Apurinic/apyrimidinic endonuclease/redox effector factor-1 (APE/Ref-1) is a multifunctional protein involved both in DNA base excision repair and redox regulation. Studies have suggested that abnormal Ref-1 levels and/or activities are associated with tumor progression and sensitivities to treatment, but no direct evidence has yet been published regarding the role of Ref-1 in malignant transformation. We utilized the well-documented tumor promotor-sensitive JB6 mouse epithelial cell model as well as new transformants [by ultraviolet light B (UVB), H2O2 or Cd] to study this phenomenon.

Significant increases of reactive oxygen species (ROS) were observed in JB6P+ and all the transformants compared with promotor-resistant JB6P– cells. These increases were paralleled by a sustained elevation of Ref-1 expression. Further analysis exhibited a strong inverse correlation between oxidative DNA lesions [8-oxodeoxyguanosine (8-oxo-dG)] and Ref-1 levels in all JB6 cells. Notably, apoptosis occurred after knock-down of Ref-1 by small interfering RNA (siRNA)] demonstrated by a ~ 2-fold increase of Annexin V-positive JB6P+ cells. Ref-1 depletion also inhibited 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced anchorage-independent growth of JB6P+ by 40% and reduced the colony numbers of JB6P+/H2O2 and JB6P+/Cd cells. Mechanistic studies revealed that Ref-1 reduction was associated with an increase of intracellular ROS levels and a marked decrease of activator protein-1 (AP-1) transcription activities in JB6P+/H2O2 cells.

This is the first report of the novel role of Ref-1 in cellular transformation. Based on the data presented here, we propose that induction of Ref-1, serving as an adaptive response to elevated ROS, plays a critical role in transformation and protects cells from excess ROS stresses through both DNA repair and activation of transcription factors such as activator protein-1.

Abbreviations: AP-1, activator protein-1; DCF, 2,'7'-dichlorofluorescein; FITC, fluorescein isothiocyanate; HE, dihydroethidium; MAPK, mitogen-activated protein kinase; Myb, Cellular homologue of avian myeloblastosis virus oncogene; NF-{kappa}B, nuclear factor kappa B; Ref-1, redox effector factor-1; ROS, reactive oxygen species; SEAP, secreted alkaline phosphatase; si-NS, si-nonsense; si-Ref-1, small interfering RNA against Ref-1; TPA, 12-O-tetradecanoylphorbol-13-acetate; UVB, Ultraviolet light (290–320 nm); 8-oxo-dG, 8-oxodeoxyguanosine

Received February 6, 2007; revised April 13, 2007; accepted May 17, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
J. Lu, S. Zhang, D. Chen, H. Wang, W. Wu, X. Wang, Y. Lei, J. Wang, J. Qian, W. Fan, et al.
Functional characterization of a promoter polymorphism in APE1/Ref-1 that contributes to reduced lung cancer susceptibility
FASEB J, October 1, 2009; 23(10): 3459 - 3469.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M.-H. Kim, H.-B. Kim, S. Acharya, H.-M. Sohn, J. Y. Jun, I.-Y. Chang, and H. J. You
Ape1/Ref-1 Induces Glial Cell-Derived Neurotropic Factor (GDNF) Responsiveness by Upregulating GDNF Receptor {alpha}1 Expression
Mol. Cell. Biol., April 15, 2009; 29(8): 2264 - 2277.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Q. Wei, H. Jiang, C. P. Matthews, and N. H. Colburn
Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
PNAS, December 16, 2008; 105(50): 19738 - 19743.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Z. Yang, S. Yang, B. J. Misner, R. Chiu, F. Liu, and F. L. Meyskens Jr.
Nitric oxide initiates progression of human melanoma via a feedback loop mediated by apurinic/apyrimidinic endonuclease-1/redox factor-1, which is inhibited by resveratrol
Mol. Cancer Ther., December 1, 2008; 7(12): 3751 - 3760.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
K. Ando, S. Hirao, Y. Kabe, Y. Ogura, I. Sato, Y. Yamaguchi, T. Wada, and H. Handa
A new APE1/Ref-1-dependent pathway leading to reduction of NF-{kappa}B and AP-1, and activation of their DNA-binding activity
Nucleic Acids Res., August 1, 2008; 36(13): 4327 - 4336.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
G.-M. Zou and A. Maitra
Small-molecule inhibitor of the AP endonuclease 1/REF-1 E3330 inhibits pancreatic cancer cell growth and migration
Mol. Cancer Ther., July 1, 2008; 7(7): 2012 - 2021.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.